Eisinger J, Laponche A M
Rev Rhum Mal Osteoartic. 1976 Jul-Sep;43(7-9):511-6.
The authors report the results of a semi-quantitative histological study of bone carried out in 6 patients with Paget's disease treated with salmon calcitonin (about thirty injections of an average of 50 MRC units) over 8 to 14 weeks. The treatment led to a decrease in the resorption surfaces, in the number and the nucleation of the osteoclasts, and in the level of hydroxyprolinuria. Cessation of treatment led to an increase in these parameters, but starting from the fifth month after the cessation renewed improvement was noted, concerning in particular the hydroxyprolinuria and the nucleation of the osteoclasts and this lasted until the tenth month. The possibility of a prolonged action of calcitonin indicates that discontinuous therapy of Paget's disease should be considered (4 months per year, for example).
作者报告了一项针对6例佩吉特病患者进行的骨组织半定量组织学研究结果。这些患者接受了鲑鱼降钙素治疗(约30次注射,平均每次50 MRC单位),疗程为8至14周。治疗导致吸收表面减少,破骨细胞数量及核仁减少,羟脯氨酸尿水平降低。停止治疗后这些参数增加,但在停止治疗后的第五个月开始再次出现改善,尤其涉及羟脯氨酸尿以及破骨细胞核仁,且这种改善持续到第十个月。降钙素具有长效作用的可能性表明,应考虑对佩吉特病进行间断治疗(例如每年4个月)。